MediWound (MDWD) Competitors

Pharvaris (NASDAQ:PHVS) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

Do analysts rate PHVS or MDWD?

Pharvaris presently has a consensus target price of $39.00, suggesting a potential upside of 111.04%. MediWound has a consensus target price of $31.33, suggesting a potential upside of 77.02%. Given Pharvaris' higher possible upside, equities analysts clearly believe Pharvaris is more favorable than MediWound.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pharvaris	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
MediWound	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has preferable valuation and earnings, PHVS or MDWD?

MediWound has higher revenue and earnings than Pharvaris. Pharvaris is trading at a lower price-to-earnings ratio than MediWound, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pharvaris	N/A	N/A	-$109.18M	-$2.68	-6.90
MediWound	$20.22M	9.46	-$6.72M	-$3.07	-5.77

Which has more volatility & risk, PHVS or MDWD?

Pharvaris has a beta of -2.84, meaning that its share price is 384% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500.

Does the MarketBeat Community believe in PHVS or MDWD?

MediWound received 360 more outperform votes than Pharvaris when rated by MarketBeat users. However, 67.27% of users gave Pharvaris an outperform vote while only 62.23% of users gave MediWound an outperform vote.

Company	Underperform	Outperform
Pharvaris	Outperform Votes 37 67.27%	Underperform Votes 18 32.73%
MediWound	Outperform Votes 397 62.23%	Underperform Votes 241 37.77%

Do insiders and institutionals have more ownership in PHVS or MDWD?

46.8% of MediWound shares are owned by institutional investors. 11.8% of Pharvaris shares are owned by company insiders. Comparatively, 9.2% of MediWound shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is PHVS or MDWD more profitable?

Pharvaris has a net margin of 0.00% compared to MediWound's net margin of -142.29%. Pharvaris' return on equity of -38.52% beat MediWound's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pharvaris	N/A	-38.52%	-36.69%
MediWound	-142.29%	-82.17%	-33.67%

Does the media prefer PHVS or MDWD?

In the previous week, Pharvaris had 1 more articles in the media than MediWound. MarketBeat recorded 4 mentions for Pharvaris and 3 mentions for MediWound. Pharvaris' average media sentiment score of 0.96 beat MediWound's score of 0.63 indicating that Pharvaris is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pharvaris	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
MediWound	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pharvaris beats MediWound on 9 of the 16 factors compared between the two stocks.